SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-298020
Filing Date
2022-12-05
Accepted
2022-12-05 08:00:33
Documents
14
Period of Report
2022-12-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d396371d8k.htm   iXBRL 8-K 26009
2 EX-99.1 d396371dex991.htm EX-99.1 8438
6 GRAPHIC g396371dsp001jpg.jpg GRAPHIC 9349
  Complete submission text file 0001193125-22-298020.txt   172715

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA acor-20221205.xsd EX-101.SCH 2847
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE acor-20221205_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acor-20221205_pre.xml EX-101.PRE 11259
8 EXTRACTED XBRL INSTANCE DOCUMENT d396371d8k_htm.xml XML 3402
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31938 | Film No.: 221443790
SIC: 2836 Biological Products, (No Diagnostic Substances)